异丙肾上腺素对小鼠腹膜巨噬细胞分泌及吞噬功能影响的研究

目的:研究异丙肾上腺素对脂多糖诱导BALB/C小鼠腹膜巨噬细胞分泌TNF-α,IL-10及吞噬功能的影响.方法:分别以10μM、100μM和300μM异丙肾上腺素加入BALB/C小鼠腹膜巨噬细胞培养液,2h后用脂多糖(LPS,10μg/mL)刺激,孵育6h后以ELISA法测定上清中TNF-α水平,24h后测定上清中IL-10的含量,并观察腹膜巨噬细胞时中性红吞噬能力的变化.结果:异丙肾上腺素使BALB/C小鼠腹膜巨噬细胞分泌TNF-α降低,IL-10分泌增加,增加巨噬细胞对中性红的吞噬能力.结论:异丙肾上腺素能调节巨噬细胞分泌功能及吞噬功能,使炎性因子分泌减少,抑炎因子分泌增多,增强巨噬细胞吞噬中性红的能力.     

法舒地尔对异丙肾上腺素诱导大鼠心肌肥厚的干预作用及其机制

目的：研究法舒地尔对异丙肾上腺素诱导大鼠心肌肥厚的影响及其机制。方法：除正常对照组外,其它SD大鼠均皮下注射异丙肾上腺素（Iso,5 mg/kg）建立心肌肥厚模型。大鼠随机分为4组：正常对照组、Iso模型组、法舒地尔低剂量组（Fas,5 mg/kg,i.p）和法舒地尔高剂量组（Fas,20 mg/kg,i.p）,连续给药8周。给药结束后,血流动力学检测大鼠心率（HR）、左心室收缩压（LVSP）、左心室末舒张压（LVEDP）和左室压力变化最大速率（±dp/dt_max）;分别测定大鼠体重（BW）,心脏重量（HW）,并计算HW/BW;大鼠心肌HE、Masson染色观察组织病理学改变;免疫组化法观察大鼠心肌组织ERK1、ERK2蛋白表达,RT-PCR观察ERK1、ERK2 mRNA的表达。结果：Iso模型组HR和LVEDP明显升高,LVSP和±dp/dt_max明显下降;HW/BW增大;心肌细胞体积变大,排列紊乱,胶原纤维增生;左心室组织ERK1、ERK2蛋白与mRNA表达上调。法舒地尔不同剂量干预后,心脏收缩和舒张能力得到改善,心指数明显下降,心肌细胞体积变小,纤维化减少,ERK1/2 mRNA表达下调,心肌组织损害均得到不同程度改善。结论：ERK1/2信号通路活化参与了异丙肾上腺素诱导的心肌肥厚,法舒地尔对异丙肾上腺素诱导的心肌肥厚具有明显改善作用,这可能与法舒地尔阻断ERK1、ERK2通路活化有关。     

过氧亚硝基阴离子对离体兔肺动脉反应性变化的影响

探讨过氧亚硝基阴离子(peroxynitrite,ONOO^-)对离体兔肺动脉反应性变化的影响。用离体血管环技术观察ONOO^-孵育后肺动脉对钙离子载体A23187、ADP、ACh、硝普钠(sodium nitroprusside,SNP)和苯肾上腺素(phe-nylephrine,PE)的反应性张力变化。结果显示：(1)ONOO^-孵育后肺动脉对A23187、ADP和ACh引起的舒张反应明显降低,ONOO^-抑制内皮依赖受体依赖或受体非依赖性舒张反应有量效关系;(2)ONOO^-孵育可剂量依赖性抑制肺动脉对SNP的舒张反应;(3)0．5mmol／L ONOO^-孵育后肺动脉对PE的收缩反应明显增强,而1．0和2．0mmol／L ONOO^-导致肺动脉的收缩反应明显降低;(4)溶剂对肺动脉的反应性无明显影响,dec ONOO^-对PE和ADP的反应性影响不大,但可增强A23187、ACh和SNP的舒张反应。结果表明,ONOO^-可改变离体肺动脉的反应性。     

异丙肾上腺素对大鼠心内神经节中生长抑素(SS)影响的研究

研究异丙肾上腺对心内神经节中肽能神经递质 SS的影响 ,本文在大鼠皮下注射异丙肾上腺素 5 m g/ kg,连续三天 ,固定后取心房后壁 ,用免疫组织化学结合图像分析方法观察大鼠心内神经节中肽能递质 SS的变化。对照组大鼠心内神经节中含有 SS免疫反应 (SS- IR)阳性神经纤维和细胞 ;实验组大鼠心内神经节中 SS- IR阳性神经纤维和神经元的积分光密度均明显减低。结果说明异丙肾上腺素可降低心内神经节中 SS含量 ,提示 ,异丙肾上腺素的正性变时和变力作用可能通过降低 SS的含量来实现。     

丹参酮Ⅱ-A磺酸钠对心肌和溶血的作用

离体豚鼠心脏灌流中,丹参酮Ⅱ-A 磺酸钠0.5—20μg/ml 灌流20分钟,随浓度而加重抑制心脏收缩幅度。麻醉大白鼠静脉注射40 mg/kg 能轻度增加在位心脏收缩幅度。0.1mg/ml对离体兔左心室乳头肌在缺氧条件下,电刺激收缩幅度下降一半所需要的时间延长。0.02或0.1mg/ml 使兔红细胞在低渗条件下的破裂减少,又减少牛血清白蛋白凝固。25—75μg/ml 对离体豚鼠左心室乳头肌膜电位和动作电位的振幅和时程无明显影响。     

丹参酮Ⅱ-A磺酸钠对分离的豚鼠心室肌单细胞慢反应动作电位的作用

分离的成年豚鼠心室肌单细胞在高钾(25mmol/L)溶液中部分除极化使钠通道失活,用细胞内刺激诱发慢反应动作电位。20μmol/L 的丹参酮Ⅱ-A 磺酸钠对这种慢反应动作电位有明显的抑制作用。在1—20μmol/L 浓度范围内,丹参酮Ⅱ-A 磺酸钠对0.28μmol/L 的异丙肾上腺素强化的慢反应动作电位有浓度依赖性抑制作用。而且,随异丙肾上腺素浓度的增加(69 nmol/L—0.55μmol/L)抑制作用更加明显。以上结果提示丹参酮 Ⅱ-A 磺酸钠可能是一种钙拮抗剂。50—100μmol/L 的丹参酮 Ⅱ-A 磺酸钠使分离的成年豚鼠心室肌单细胞快反应动作电位的幅度降低,达峰值的时间延长。提示高浓度的丹参酮 Ⅱ-A 磺酸钠对钠通道也有一定的阻断作用。     

增加Gi和β2AR表达对异丙肾上腺素损伤的大鼠心肌细胞存活的影响

目的：观察增加β2肾上腺素受体（β2AR）和抑制性G蛋白（Gi）基因的表达是否可改善长期异丙肾上腺素（ISO）刺激引起的心肌细胞死亡。方法：用腺病毒作载体,在培养的心肌细胞增加β2AR和Gi基因的表达;然后在培养基中加入5μmol/L的异丙肾上腺素以损伤心肌细胞,24h后记数各组细胞的存活率。结果：β2AR和Gi表达增加,对正常培养的大鼠心肌细胞的死亡率均没有影响,但能够减少异丙肾上腺素损伤引起的细胞死亡。这种作用可分别被β2AR选择性阻断剂ICI118,551和Gi阻断剂百日咳毒素（PTX）所阻断。结论：增加β2AR或Gi基因的表达,对异丙肾上腺素损伤的心肌细胞有保护作用。     

肾性高血压大鼠左室等容峰压一容积关系及其对异丙肾上腺素的反应

本研究观察了肾血管性高血压大鼠(RHR)肥大左室的等容峰压-容积关系(PIPVR)和左室压力最大上升速率-容积关系(PRPVR)的曲线特征,并用两曲线的升支斜率E_(max)和dE/dt_(max)及曲线的特征参数评价了RHR(8周)左室的收缩能力及其对异丙肾上腺素的反应性。结果显示,大鼠高血压8周后左室发生明显肥大;与同龄假手术对照大鼠(SOR)相似,RHR的PIPVR和PRPVR也呈指数曲线形式;与SOR比较,RHR左室的PIPVR和PRPVR左上移位,E_(max)、dE/dt_(max)显著增大(P均<0.01),分别增加78％和97％,曲线的特征参数K_1、K_2、B_1和B_2也明显高于SOR(P均<0.05),分别增加37％、32％、25％和57％;灌注异丙肾上腺素(0.94μg/min)后,上述指标的增加幅度均较SOR低(P均<0.05)。结果提示,压力超负荷心肌肥大并不影响PIPVR的非线性特征,基础状态下,RHR肥大左室的收缩能力增强,但对异丙肾上腺素的反应性降低。     

异丙肾上腺素激发试验在大鼠酒精性心肌病模型评价中的应用

目的:建立大鼠酒精性心肌病模型,采用异丙肾上腺素激发试验评价模型大鼠心功能。方法:成年雄性SD大鼠以20 g/(kg.d)白酒(52°v/v)灌胃15 d。观察大鼠一般状况、心肌标本病理学及超微结构改变;通过左心室插管、异丙肾上腺素试验(IPT),测量大鼠在不同状态下的左心室内压、收缩压、舒张压、最大收缩速度、最大舒张速度。结果:模型组大鼠心脏舒缩功能降低,心力储备明显下降,心血管系统整体调节能力降低。病理见心肌细胞肥大、坏死,炎症细胞浸润;电镜见线粒体肿胀变形,嵴受损,肌原纤维断裂。结论:高度酒灌胃可使大鼠发生酒精性心肌病,该法稳定可靠。异丙肾上腺素试验(IPT)可准确考察心脏心力储备状况,显现潜在心功能减退。     

不同年龄大鼠心肌细胞瞬时外向钾电流的变化

本文旨在研究心肌细胞瞬时外向钾电流(transient outward potassium current,Ito)的随龄变化及其药物反应性改变。Sprague Dawley大鼠28只,分为青年组(3~5月龄)、成年组(13~15月龄)和老年组(22~24月龄)。酶法分离心室肌细胞,应用全细胞膜片钳技术记录各组Ito。并于细胞外液分别加入1.0μmol/L异丙肾上腺素和2.0mmol/L4-氨基吡啶干预,观察Ito的变化。结果显示,与青年组和成年组相比,老年组Ito电流密度显著增加。门控动力学研究显示,老年组Ito电流稳态激活曲线左移,通道关闭态失活速率明显降低,稳态失活后恢复速率加快,而稳态失活过程无明显变化。老年组Ito对选择性抑制剂4-氨基吡啶的反应性与青年组和成年组相似,但老年组Ito对β受体激动剂异丙肾上腺素的反应性却明显弱于青年组和成年组,各组电流密度分别增加55.9%、127.5%和125.8%。上述结果提示,随着大鼠年龄的增加,心肌细胞Ito电流密度显著升高,与通道门控的激活、关闭态失活和失活后恢复机制改变有关,且老年鼠Ito对异丙肾上腺素的反应性降低。     

迷走神经在心率变异性中的作用

采用功率谱和近似熵 (approximateentropy ,ApEn)的方法 ,分析清醒家兔在双侧迷走神经保留 ,右、左侧迷走神经切断以及双侧迷走神经同时切断时心搏间期 (RRI)的变化。结果显示 :双侧迷走神经保留时功率谱中高频功率 (HF)、低频功率 (LF)及ApEn值均高于双侧及单侧迷走神经切断时 (P <0 0 5 ) ,LF/HF比值最小 ;切断单侧迷走神经 ,ApEn变小 ,LF/HF比值在右侧迷走神经切断时增大 ,而切断左侧迷走时LF/HF比值无明显变化 ;双侧迷走神经切断后LF/HF比值最大 ,ApEn最低。结果表明 :心率变异主要由迷走神经调节 ,右侧迷走神经起主要作用 ;传统心率变异性测量方法与非线性方法所得结果一致     

Mechanism of tachycardia caused by intracarotid PGE2 in conscious ewes

Conscious adult ewes prepared with nonocclusive indwelling vascular catheters were used to determine the mechanism by which heart rate increases during central administration of prostaglandin E2 (PGE2). Heart rate increased 14 bpm during steady-state intracarotid infusion of PGE2, 10 ng/kg/min (P less than 0.05). Intravenous atropine methyl bromide, 1 mg/kg, increased heart rate 26 bpm (P less than 0.05) 5 min after injection. Heart rate remained elevated 30 min after injection. The heart rate response to PGE2 plus atropine was greater than the heart rate response to either atropine or PGE2 alone (P less than 0.05). Propranolol, 1 mg/kg bolus plus intravenous infusion, 0.025 mg/kg/min, did not change resting heart rate. Propranolol attenuated but did not abolish the increase in heart rate caused by intracarotid PGE2. Although heart rate increased in response to PGE2 after administration of either propranolol or atropine alone, the combination of propranolol and atropine prevented any further increase in heart rate during subsequent PGE2 infusion. The increase in heart rate when all three drugs were given together was not different from the increase observed during atropine alone. Thus, both beta-adrenergic activation and muscarinic deactivation contribute to the PGE2-induced tachycardia.     

Studies on bradycardia mechanism in the moderately hypothermic dog.

Chronotropic action of isoprenaline on the heart was studied in anesthetized dogs, in euthermic and moderate hypothermic conditions, before and after intravenous administration of atropine and oxprenolol or a cervical bilateral vagotomy. In moderate hypothermia we observed: i) larger duration of the positive chronotropic response to isoprenaline with a delayed and slightly lesser intensity in its maximum; ii) relating to euthermic conditions, delayed but superimposed potentiation of the chronotropic isoprenaline response in atropinized or vagotomized dogs; iii) a small negative chronotropic response to isoprenaline 15 min after oxprenolol, that diminished after atropine; iiii) oxprenolol induced a marked bradycardia nearly twice as intense as in euthermic dogs, almost completely blocked subsequently by atropine. It is concluded that progressive bradycardia in the moderately hypothermic dog is due, among other factors, to a cholinergic action but not to a lesser ability of beta-adrenergic cardiac effectors to chronotropic responses.     

Vagal cardiac function and arterial blood pressure stability

This study was designed to investigate the importance of vagal cardiac modulation in arterial blood pressure (ABP) stability before and after glycopyrrolate or atropine treatment. Changes in R-R interval (RRI) and ABP were assessed in 10 healthy young (age, 22 +/- 1.8 yr) volunteers during graded lower body negative pressure (LBNP) before and after muscarinic cholinergic (MC) blockade. Transient hypertension was induced by phenylephrine (1 microg/kg body wt), whereas systemic hypotension was induced by bilateral thigh cuff deflation after a 3-min suprasystolic occlusion. Power spectral densities of systolic [systolic blood pressure (SBP)] and diastolic ABP variability were examined. Both antimuscarinic agents elicited tachycardia similarly without significantly affecting baseline ABP. The increase in SBP after phenylephrine injection (+14 +/- 2 mmHg) was significantly augmented with atropine (+26 +/- 2 mmHg) or glycopyrrolate (+27 +/- 3 mmHg) and associated with a diminished reflex bradycardia. The decrease in SBP after cuff deflation (-9.2 +/- 1.2 mmHg) was significantly greater after atropine (-15 +/- 1 mmHg) or glycopyrrolate (-14 +/- 1 mmHg), with abolished reflex tachycardia. LBNP significantly decreased both SBP and RRI. However, after antimuscarinic agents, the reduction in SBP was greater (P < 0.05) and was associated with less tachycardia. Antimuscarinic agents reduced (P < 0.05) the low-frequency (LF; 0.04-0.12 Hz) power of ABP variability at rest. The LF SBP oscillation was significantly augmented during LBNP, which was accentuated (P < 0.05) after antimuscarinic agents and was correlated (r = -0.79) with the decrease in SBP. We conclude that antimuscarinic agents compromised ABP stability by diminishing baroreflex sensitivity, reflecting the importance of vagal cardiac function in hemodynamic homeostasis. The difference between atropine and glycopyrrolate was not significant.     

Vectorcardiography analysis of the repolarization response to pharmacologically induced autonomic nervous system modulation in healthy subjects

Autonomic nervous system activity is essential for regulation of ventricular repolarization (VR) and plays an important role in several arrhythmogenic conditions. This study in 31 healthy adult subjects (16 men, 15 women) evaluated the VR response to pharmacologically modulated autonomic nervous system activity applying vectorcardiography (VCG) analysis. During continuous VCG recording, 0.01-0.1 μg·kg(-1)·min(-1) isoprenaline (Iso) was infused at an increasing flow rate until three targeted heart rates (HR) were reached. After Iso washout, one intravenous bolus of 0.04 mg/kg atropine was given followed by an intravenous bolus of 0.2 mg/kg propranolol. A 5-min steady-state VCG recording was analyzed for each of the seven phases (including baseline 1 and 2). Furthermore, during the first 4 min following atropine, six periods of 10-s VCG were selected for subanalysis to evaluate the time course of change. The analysis included QRS, QT, and T-peak to T-end intervals, measures of the QRS and T vectors and their relation, as well as T-loop morphology parameters. By increasing HR, Iso infusion decreased HR dependent parameters reflecting total heterogeneity of VR (T area) and action potential morphology (ventricular gradient). In contrast, Iso prolonged QT HR corrected according to Bazett and increased the T-peak to T-end-to-QT ratio to levels observed in arrhythmogenic conditions. HR acceleration after atropine was accompanied by a transient paradoxical QT prolongation and delayed HR adaptation of T area and ventricular gradient. In addition to the expected HR adaptation, the VR response to β-adrenoceptor stimulation with Iso and to muscarinic receptor blockade with atropine thus included alterations previously observed in congenital and acquired long QT syndromes, demonstrating substantial overlap between physiological and pathophysiological electrophysiology.     

Relationship between cortical electrical and cardiac autonomic activities in the awake lizard, Gallotia galloti

ECG and EEG signals were simultaneously recorded in lizards, Gallotia galloti, both in control conditions and under autonomic nervous system (ANS) blockade, in order to evaluate possible relationships between the ANS control of heart rate and the integrated central nervous system activity in reptiles. The ANS blockers used were prazosin, propranolol, and atropine. Time-domain summary statistics were derived from the series of consecutive R-R intervals (RRI) of the ECG to measure beat-to-beat heart rate variability (HRV), and spectral analysis techniques were applied to the EEG activity to assess its frequency content. Both prazosin and atropine did not alter the power spectral density (PSD) of the EEG low frequency (LF: 0.5-7.5 Hz) and high frequency (HF: 7.6-30 Hz) bands, whereas propranolol decreased the PSD in these bands. These findings suggest that central beta-adrenergic receptor mechanisms could mediate the reptilian waking EEG activity without taking part any alpha(1)-adrenergic and/or cholinergic receptor systems. In 55% of the lizards in control conditions, and in approximately 43% of the lizards under prazosin and atropine, a negative correlation between the coefficient of variation of the series of RRI value (CV(RRI)) and the mean power frequency (MPF) of the EEG spectra was found, but not under propranolol. Consequently, the lizards' HRV-EEG-activity relationship appears to be independent of alpha(1)-adrenergic and cholinergic receptor systems and mediated by beta-adrenergic receptor mechanisms.     

Systemic NO synthase inhibition blunts the chronotropic, but not the inotropic response to isoprenaline in man.

There is evidence that nitric oxide (NO) is involved in the chronotropic, the inotropic, and the vasodilator response to beta-adrenoceptor agonists. In the present study we hypothesized that inhibition of NO synthase may modulate the systemic vascular and cardiac effects of isoprenaline, a beta-adrenoceptor agonist, in healthy subjects. Subjects received stepwise increasing doses of isoprenaline (0.1-0.8 microg/min) in the absence or presence of systemic NO-synthase inhibition using two intravenous doses of N-monomethyl-L-arginine (L-NMMA; dosage 1, 3.0 mg/kg over 5 min, followed by 30 microg/kg/min over 75 min; dosage 2, 6.0 mg/kg over 5 min, followed by 60 microg/kg/min over 75 min) or peripheral vasoconstriction using exogenous endothelin-1 (ET-1; 5.0 ng/kg/min for 80 min). The chronotropic (RR interval) and the inotropic (QS2c) responses were assessed by noninvasive measurement of systolic time intervals. L-NMMA alone did not influence QS2c, but did increase the RR interval (P < 0.001) and the mean arterial blood pressure (P = 0.003). L-NMMA did not attenuate the blood pressure and the QS2c responses to isoprenaline, but significantly and dose-dependently blunted the heart rate response to beta-adrenoceptor stimulation (P = 0.029). ET-1 decreased the RR interval (P < 0.001) and increased the mean arterial blood pressure (P = 0.028). Our results indicate that beta-adrenoceptor mediated effects on the heart rate are much more susceptible to NOS inhibition than inotropic responses. This indicates that NO has an important role in heart rate control during beta-adrenoceptor stimulation.     

白细胞介素-1β对实验性急性缺氧诱导的大鼠窦神经放电的影响

最近的研究显示,颈动脉体（carotid body,CB）除具有缺氧等化学感受功能外,还对白细胞介素-1B（IL-1β）的刺激起反应。但是,IL-1β刺激对颈动脉体的缺氧感受功能有何影响还不清楚。本研究运用在体（in vivo）细胞外神经干电位记录的方法,利用麻醉大鼠,观察了CB局部给予IL-1β对实验性急性缺氧（experimental acute hypoxia,EAH）诱导的CB传入神经窦神经（carotid sinus nerve,CSN）放电频率的影响。结果发现,EAH可以诱导麻醉状态下大鼠的CSN放电频率增高;颈动脉体局部给予ATP（0、1mmol／L）和ACh（0,5mmol／L）在一定程度上可模拟缺氧诱导的CSN放电;局部给予ILlp（40μg／L）可诱导窦神经放电频率增加。但同时给予IL-1B和EAH,所引起的放电频率增高效应与单独给予EAH或IL-1β所诱导的放电频率的增高效应间无显著性差别,且IL-1β对ATP和ACh诱导的窦神经放电的增高效应也无显著影响。这些结果提示,IL-1β对EAH诱导的窦神经放电无调节作用。     

Gardiovascular responses to prostaglandin f2α in spontaneously hypertensive rats

To test the hypothesis that abnormal prostaglandin reactivity may be a characteristic of essential hypertension, cardiovascular responses to prostaglandin F_2α (PGF_2α) were measured in young spontaneously hypertensive (SHR) and Wistar normotensive rats (NR). PGF_2α(1 sec injection; 50 l/100 g.; .05, .5, 5, 50 g salt/kg) was injected retrograde into the femoral artery. Maximum changes were measured with respect to: 1) four different diameter categories of cremaster muscle arterioles, 2) mean arterial pressure (MAP), 3) pulse pressure (PP) and 4) heart rate. PGF_2α at 5 and 50 g/kg significantly increased NR and SHR blood pressure. SHR MAP increased significantly more than NR MAP with the 50 g dose (P <. 001). PGF_2α increased NR PP at the 50 g/kg dose and increased SHR PP at the .5, 5 and 50 g/kg dose. SHR PP response was significantly greater than that of the NR with the .5, 5 and 50 g/kg dose (P < .05, .01, .001 respectively). The mean SHR arteriolar constriction was greater than that of NR with the 50 g dose. The only change in heart rate was a 3% decrease from control in both NR and SHR during the pressor response to 50 g/kg. These results show an increased cardiovascular reactivity to PGF_2α in SHR and may further suggest prostaglandin involvement in hypertensive disease.     

Effects of Salbutamol and Isoprenaline Phenylephrine in Reversible Airways Obstruction

Ventolin (salbutamol) and Medihaler-Duo (isoprenaline/phenylephrine combination) standard pressurized inhalers were used to administer doses of two or six “puffs” to 16 patients with known reversible airways obstruction. The doses were administered in random order over two days. Both the Ventolin and Medihaler-Duo inhalers substantially increased FEV₁, but in the doses used salbutamol was more effective than isoprenaline/phenylephrine (P < 0·01). There was no significant difference between two and six puffs of salbutamol, though there seemed to be an advantage of six puffs of isoprenaline/phenylephrine over two puffs (P < 0·05). Adrenaline (1/1,000) 0·5 ml and atropine 0·6 mg produced similar increases in FEV₁ to those produced by salbutamol.The Pao₂ fell more than 5 mm Hg in three patients after salbutamol and in three after isoprenaline/phenylephrine. There was no significant fall in mean Pao₂ in any of the treatment groups. It is concluded that the Ventolin inhalant, administered in the conventional dose of two puffs, is as effective a bronchodilator as subcutaneous adrenaline and atropine, is more effective than the Medihaler-Duo, and is without detectable side effects.